Greg Abel Just Sold Both Visa and Mastercard Stock but Kept This Top Buffett Favorite

American Express is highlighted as a durable compounder that Berkshire Hathaway kept while trimming Visa and Mastercard, reinforcing Buffett/Abel's confidence in its business model. The article cites AmEx's fee-based membership model, affluent customer focus, and closed-loop system, along with five-year outperformance versus Visa, Mastercard, and the S&P 500. Q1 2026 fees rose 18% year over year and accounted for 14% of revenue, but the piece is primarily a long-term bull case rather than new market-moving news.

Analysis

AXP’s relative strength is less about brand and more about economics: it monetizes the cardholder relationship twice, first through recurring fees and then through balance-sheet spread capture. That gives it a different earnings reflex than V/MA, which are structurally cleaner networks but depend more on volume growth and less on direct monetization per customer. In a world where premium consumers remain employed and spending, the closed-loop model can compound faster than the market assumes because richer customers tend to trade down less in discretionary downturns.

The second-order effect is that the current narrative likely understates positioning risk for V and MA rather than overstates AXP. If large allocators increasingly frame AmEx as the “quality” card compounder, network-only processors could see valuation multiples compress even without any deterioration in fundamentals, simply because the moat discussion shifts from scale to monetization depth. That matters most over the next 6–12 months: if spending remains resilient, the market may continue rewarding AXP’s higher fee intensity and balance-sheet optionality, but a slowdown would hit the same affluent cohort later rather than earlier.

The main bear case on AXP is not competition; it is credit normalization. The model is more levered to underwriting discipline than Visa/Mastercard, so any rise in delinquencies or reserve builds could puncture the premium multiple quickly. But that risk is probably still underappreciated because the stock has already proven it can outperform through volatility, which often causes investors to extrapolate durability and underprice cyclical downside.

Key Decisions for Investors

• Stay long AXP into the next 1-2 quarters as a quality-compounder trade; preferred expression is a core long with a 12-month horizon, targeting continued multiple premium persistence if affluent spending stays firm.
• Reduce or hedge V/MA exposure versus AXP on valuation/quality spread: pair long AXP vs short a basket of V/MA for 3-6 months, expecting relative multiple divergence if the market keeps rewarding monetization depth over pure network quality.
• Use downside protection on AXP if entering now: buy 3-6 month put spreads to protect against a credit surprise, since the primary risk is reserve build / delinquency re-rate rather than volume decay.
• If you want event-driven entry, add on any pullback tied to macro scare rather than card-specific issues; the risk/reward is better when the market temporarily prices AXP like a cyclical lender instead of a premium consumer franchise.
• Avoid chasing V or MA on the thesis that they are 'safer' substitutes; their upside is more dependent on market multiple expansion, while AXP has a clearer operating lever if consumer spending stays intact.